BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 15, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2017
View Archived Issues
FDA awards orphan drug designation to Cascadian's tucatinib
Read More
AzurRx reports initial data from ongoing phase IIa trial of MS-1819-SD
Read More
Synergys Biotherapeutics receives grant to support SYN-001 development
Read More
Diamyd to design first clinical trial of Remygen
Read More
NIDA grant supports Camino Pharma's development of compounds for substance use disorders
Read More
New lung cancer study to utilize Inivata's InVision liquid biopsy platform
Read More
Safety explored in first-in-human study of KHK-4083, a monoclonal antibody targeting OX40
Read More
Eidos Therapeutics doses first cohort in AG-10 phase I study
Read More
Topline results from phase I/II study of SciFluor's SF-0166 for DME
Read More
Inhaled sodium cromoglycate formulation PA-101 reduces cough in IPF patients
Read More
Villin-1 as a biomarker of intestinal ischemia reperfusion injury
Read More
Achaogen awarded contract for development of C-Scape
Read More
Protagenic Therapeutics' PT-00114 shows efficacy in animal models
Read More
GlaxoSmithKline divulges CD73 inhibitors
Read More
FDA gives Emergency Use Authorization to Chembio for DPP Zika system test
Read More
Merck & Co. patents novel monobactam derivatives for bacterial infections
Read More
Raze Therapeutics identifies 3-PGDH inhibitors
Read More
Global Alliance for TB Drug Development patents compounds for tuberculosis
Read More
New York University discloses Wnt signaling inhibitors
Read More
FDA grants orphan drug designation to rimeporide for Duchenne muscular dystrophy
Read More
SI-613 begins phase II trial in Japan for enthesopathy
Read More
FDA approves Verzenio in breast cancer
Read More
Japanese orphan drug designation for olaparib for BRCA-positive breast cancer
Read More
First subject enrolled in phase III study of TRC-101 in chronic kidney disease
Read More
Quidel announces progress in acquisition of Alere's BNP business
Read More
FDA grants priority review to Amitiza sNDA for pediatric functional constipation
Read More
TLR3 identified as novel target for preventing cardiac ischemia reperfusion injury
Read More
Phase Ib data do not support progression of PRX-003 for psoriasis
Read More
U.S. contract supports progression of InBios point-of-care diagnostic test for B. anthracis
Read More
Zynerba reports promising data from phase II trial of ZYN-002 for fragile X syndrome
Read More
Curemark completes enrollment in phase III trial of CM-AT in autism
Read More
FDA grants priority review to Linhaliq NDA
Read More
FDA priority review for Perjeta sBLA for adjuvant treatment of HER2-positive early breast cancer
Read More
NIAID grant supports development of thermostable trivalent Ebola vaccine
Read More